FDA Approved Medical Products for:

Familial myelofibrosis

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Ruxolitinib Phosphate
Trade Name
(Manufacturer Name)
(Incyte Corporation)
The FDA has approved this product to be used in this manner.
Treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis. Treatment of patients with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea.
More Information about this product Drug Information Portal
Medline Plus Health Information